SENSIENT TECHNOLOGIES CORP·4

Jul 1, 5:58 PM ET

Carleone Joseph 4

4 · SENSIENT TECHNOLOGIES CORP · Filed Jul 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Sensient (SXT) Director Joseph Carleone Receives 296 Share Award

What Happened

  • Joseph Carleone, a director of Sensient Technologies Corp (SXT), was granted 296.253 shares on 2026-06-30. The award is recorded at a $0 acquisition price (no cash paid) and is reported as a derivative grant/award (transaction code A). This appears to be director compensation rather than an open-market purchase or sale.

Key Details

  • Transaction date: 2026-06-30; Form 4 filed: 2026-07-01 (appears timely).
  • Shares granted: 296.253; price per share: $0.00; total cash value at grant: $0 (award/deferral).
  • Transaction type: Award/Grant (derivative), likely deferred stock or restricted stock units under the issuer's plans.
  • Shares owned after transaction: Not specified in the provided filing details.
  • Relevant footnotes from the filing:
    • F1: Includes restricted stock under the 2017 Stock Plan and shares held in a dividend reinvestment plan.
    • F2: Deferred stock converts to common stock on a one-for-one basis.
    • F3: Grant results from deferral of director fees under the Directors' Deferred Compensation Plan.
    • F4: Common shares will be issued upon termination of the reporting person's service as a director (i.e., vesting/issuance tied to service termination).

Context

  • This is a routine director compensation award (deferred/restricted shares) and not an outright purchase or sale. Such grants compensate service and may convert to common stock per plan terms; they do not by themselves signal a buy/sell decision by the insider.

Insider Transaction Report

Form 4
Period: 2026-06-30
Transactions
  • Award

    Deferred Stock

    [F2][F3][F4]
    2026-06-30+296.25324,163.893 total
    Common Stock (296.253 underlying)
Holdings
  • Common Stock

    [F1]
    23,735.029
Footnotes (4)
  • [F1]Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
  • [F2]Deferred stock converts to common stock on a one-for-one basis.
  • [F3]Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
  • [F4]Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone|2026-07-01

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT